Avid recently experienced one of the worst "own goals" that I have ever seen in public markets, but despite this blunder and resultant stock pullback, the long-term thesis is very much intact. Avid is ...

Avid Bioservices (NASDAQ:CDMO), a contract manufacturer for the biopharma industry, lost ~37% premarket Thursday after its preliminary Q3 results for fiscal 2024 fell short of expectations, and the ...

We recently compiled a list of the 10 Best Small-Cap Healthcare Stocks To Buy Now. In this article, we are going to take a look at where Avid Bioservices, Inc. (NASDAQ:CDMO) stands against the other ...

Avid reported quarterly fiscal results on Tuesday. The company reported sales of $43 million beating analyst estimates of $42.14 million. Every week, our Whisper Index uncovers five overlooked stocks ...

Avid Bioservices CDMO shares rallied 7.2% in the last trading session to close at $23.38. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...